Immunoengineering VI: T cell Responses in Cancer Immunotherapy

Session Chair(s)

• 

  Nzinga Mack, PhD (she/her/hers)

  Postodoctoral fellow
  Johns Hopkins University
  Baltimore, Maryland, United States
• NC

  Namit Chaudhary

  MIT

Track Chair(s)

• 

  Michelle Teplensky, PhD (she/her/hers)

  Assistant Professor
  Boston University
  Boston, Massachusetts, United States
• JW

  John Wilson

  Associate Professor
  Vanderbilt University
  Nashville, Tennessee, United States
• LW

  Liz Wayne

  University of Washington

Presentations:

• 12:30 PM – 12:45 PM EST

  Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver
  

  Presenting Author: Jeffrey Yang (he/him/his) – University of Maryland, College Park

  Co-Author: Andrew S. Mikhail, PhD – Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health

  Co-Author: Hannah Huth, BA – National Institutes of Health

  Co-Author: Robert Morhard, PhD (he/him/his) – Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health

  Co-Author: Baktiar Karim – Frederick National Laboratory for Cancer Research

  Co-Author: John W. Karanian, PhD – Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health

  Primary Investigator: Bradford J. Wood, MD (he/him/his) – National Institutes of Health

  Last Author: Jenna Mueller, PhD (she/her/hers) – University of Maryland
• 12:45 PM – 1:00 PM EST

  Characterization of senescent stromal cells in the tumor microenvironment treated with immune checkpoint blockade
  

  Presenting Author: John Michel – Johns Hopkins University

  Co-Author: Matthew T. Wolf, PhD (he/him/his) – National Cancer Institute

  Co-Author: Elise F. Gray-Gaillard, MSc (she/her/hers) – Johns Hopkins University

  Co-Author: Anna Ruta, PhD – Johns Hopkins University

  Co-Author: Radhika Narain – University of California at Berkeley

  Co-Author: Katlin B. Stivers, PhD (she/her/hers) – Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

  Co-Author: Kavita Krishnan – Johns Hopkins University

  Co-Author: Christopher Cherry, PhD – C. M. Cherry Consulting

  Co-Author: Tricia Cottrell, MD, PhD – Queen’s Cancer Research Institute

  Co-Author: Sudipto Ganguly, PhD – Johns Hopkins School Of Medicine

  Co-Author: Franck Housseau, PhD – Associate Professor of Oncology

  Co-Author: Drew Pardoll, M.D., Ph.D. – Johns Hopkins University

  Last Author: Jennifer H. Elisseeff, PhD – Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

  Co-Author: Sushma Nagaraj, MS – Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

  Co-Author: Elana J. Fertig, PhD – Johns Hopkins University

  Co-Author: Valsamo Anagnostou
• 1:00 PM – 1:15 PM EST

  Potentiate mRNA Lipid Nanoparticle-mediated Anticancer Immunity by Optimizing Th1 and Th2 Immune Activation Profile
  

  Presenting Author: Christine Wei, BS (she/her/hers) – Johns Hopkins University

  Co-Author: Yining Zhu, MSE (he/him/his) – Johns Hopkins University

  Co-Author: Jingyao Ma, MSE (he/him/his) – Johns Hopkins University

  Primary Investigator: Hai-Quan Mao, PhD (he/him/his) – Johns Hopkins University

  Co-Author: Joshua C. Doloff, MA, PhD (he/him/his) – Johns Hopkins University, Depts. of Biomedical Engineering and Materials Science & Engineering, Translational Tissue Engineering Center (TTEC), and the Institute for NanoBioTechnology (INBT)

  Co-Author: Jonathan P. Schneck, MD, PhD – Johns Hopkins University

  Co-Author: Sashank Reddy – Johns Hopkins University

  Co-Author: Sean C. Murphy, MD, PhD – University of Washington
• 1:15 PM – 1:30 PM EST

  Synthetic Viscoelastic Activating Cells for T Cell Engineering and Cancer Therapy
  

  Presenting Author: Youcheng Yang (he/him/his) – UCLA

  Co-Author: Zeyang Liu, PhD – UCLA

  Co-Author: Yan-Ruide Li – UCLA

  Primary Investigator: Song Li, PhD (he/him/his) – UCLA
• 1:30 PM – 1:45 PM EST

  Thermally Ablative Focused Ultrasound Potentiates the Anti-Tumor Immunity of Neoadjuvant Checkpoint Inhibition and Vascular Normalization
  

  Presenting Author: Mark Schwartz (he/him/his) – University of Virginia

  Co-Author: Matthew DeWitt – University of Virginia

  Co-Author: Lydia Kitelinger, MS – University of Virginia

  Co-Author: Timothy Bullock – University of Virginia

  Primary Investigator: Richard Price, PhD – University of Virginia
• 1:45 PM – 2:00 PM EST

  Triple-negative Breast Cancer Growth and Immune Responses to Metronomic Chemotherapy Regimens with Varied Drugs and Dosages
  

  Presenting Author: Amanda I. Rakoski, BS (she/her/hers) – Johns Hopkins University

  Primary Investigator: Joshua C. Doloff, MA, PhD (he/him/his) – Johns Hopkins University, Depts. of Biomedical Engineering and Materials Science & Engineering, Translational Tissue Engineering Center (TTEC), and the Institute for NanoBioTechnology (INBT)

  Co-Author: Sarah Neshat (she/her/hers) – Johns Hopkins University